Long noncoding RNA endogenous bornavirus-like nucleoprotein acts as an oncogene by regulating microRNA-655-3p expression in T-cell acute lymphoblastic leukemia

References

• Gianni F, Belver L, Ferrando A. The genetics and mechanisms of T-Cell acute lymphoblastic leukemia. Cold Spring Harb Perspect Med. 2020;10:a035246.
   PubMed Web of Science ®Google Scholar
• Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119:34–43.
   PubMed Web of Science ®Google Scholar
• Coustan-Smith E, Mullighan CG, Onciu M, et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 2009;10:147–156.
   PubMed Web of Science ®Google Scholar
• Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia. 1995;9:1783–1786.
   PubMed Web of Science ®Google Scholar
• Yuan TT, Liu YR, Chang Y, et al. Characteristics of T-cell lineage immunophenotype in 95 patients with acute lymphoid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011;19:1134–1140.
   PubMedGoogle Scholar
• Jain N, Lamb AV, O’Brien S, et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127:1863–1869.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, and Hasserjian R. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. . Blood. 2016;127:2391–2405.
   PubMed Web of Science ®Google Scholar
• Kochupillai V. Emerging concepts in the management of acute lymphoblastic leukaemia. Indian J Med Res. 1993;98:1–7.
   PubMed Web of Science ®Google Scholar
• Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23:655–674.
   PubMed Web of Science ®Google Scholar
• Samra B, Jabbour E, Ravandi F, et al. Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions. J Hematol Oncol. 2020;13:70.
   PubMed Web of Science ®Google Scholar
• Jain P, Kantarjian H, Ravandi F, et al. The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson cancer center experience. Leukemia. 2014;28:973–975.
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Gökbuget N. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity? Clin Lymphoma Myeloma. Clinical Lymphoma & Myeloma. 2009;9(3):S214–221.
   PubMedGoogle Scholar
• Bongiovanni D, Saccomani V, Piovan E. Aberrant signaling pathways in T-Cell Acute lymphoblastic leukemia. Int J Mol Sci. 2017;18:1904.
   PubMed Web of Science ®Google Scholar
• Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20:460–469.
   PubMed Web of Science ®Google Scholar
• Jarroux J, Morillon A, Pinskaya M. History, discovery, and classification of lncRNAs. Adv Exp Med Biol. 2017;1008:1–46.
   PubMed Web of Science ®Google Scholar
• Ulitsky I, Bartel DP. lincRNAs: genomics, evolution, and mechanisms. Cell. 2013;154:26–46.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36:5661–5667.
   PubMed Web of Science ®Google Scholar
• Dinescu S, Ignat S, Lazar AD, et al. Epitranscriptomic signatures in lncRNAs and their possible roles in cancer. Genes (Basel). 2019;10:52.
   PubMed Web of Science ®Google Scholar
• Ward M, McEwan C, Mills JD, et al. Conservation and tissue-specific transcription patterns of long noncoding RNAs. J Hum Transcr. 2015;1:2–9.
   PubMedGoogle Scholar
• Li F, Xiao Y, Huang F, et al. Spatiotemporal-specific lncRNAs in the brain, colon, liver and lung of macaque during development. Mol Biosyst. 2015;11:3253–3263.
   PubMed Web of Science ®Google Scholar
• Wang Y, Du L, Yang X, et al. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer. Aging (Albany NY). 2020;12:2857–2879.
   PubMedGoogle Scholar
• Liu H, Zhang Q, Lou Q, et al. Differential analysis of lncRNA, miRNA and mRNA Expression profiles and the prognostic value of lncRNA in Esophageal cancer. Pathol Oncol Res. 2020;26:1029–1039.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146:353–358.
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344–352.
   PubMed Web of Science ®Google Scholar
• Dai S, Li N, Zhou M, et al. LncRNA EBLN3P promotes the progression of osteosarcoma through modifying the miR-224-5p/Rab10 signaling axis. Sci Rep. 2021;11:<yr>1992</yr>. DOI:10.1038/s41598-021-81641-6
   Web of Science ®Google Scholar
• Li H, Wang M, Zhou H, et al. Long noncoding RNA EBLN3P promotes the progression of liver cancer via alteration of microRNA-144-3p/DOCK4 signal. Cancer Manag Res. 2020;12:9339–9349.
   PubMed Web of Science ®Google Scholar
• Jiang W, Peng A, Chen Y, et al. Long non‑coding RNA EBLN3P promotes the recovery of the function of impaired spiral ganglion neurons by competitively binding to miR‑204‑5p and regulating TMPRSS3 expression. Int J Mol Med. 2020;45:1851–1863.
   PubMed Web of Science ®Google Scholar
• Mathias C, Muzzi JCD, Antunes BB, et al. Unraveling immune-related lncRNAs in breast cancer molecular subtypes. Front Oncol. 2021;11:692170.
   PubMed Web of Science ®Google Scholar
• Chen L, Shi Y, Li J, et al. LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335-3p/TRAF5 axis. Anticancer Drugs. 2020;25.
   Google Scholar
• Li G, Gao L, Zhao J, et al. LncRNA ANRIL/miR-7-5p/TCF4 axis contributes to the progression of T cell acute lymphoblastic leukemia. Cancer Cell Int. 2020;20:335.
   PubMed Web of Science ®Google Scholar
• Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016;1402:271–286.
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202–1207.
   PubMed Web of Science ®Google Scholar
• Zha JF, Chen DX. MiR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A. Eur Rev Med Pharmacol Sci. 2019;23:3627–3634.
   PubMed Web of Science ®Google Scholar
• Wang W, Cao R, Su W, et al. miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer. Biosci Biotechnol Biochem. 2019;83:1703–1708.
   PubMed Web of Science ®Google Scholar
• Zhao XQ, Liang B, Jiang K, et al. Down-regulation of miR-655-3p predicts worse clinical outcome in patients suffering from hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2017;21:748–752.
   PubMed Web of Science ®Google Scholar
• Zhang B, Sun YF, Zhang XM, et al. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis. Eur Rev Med Pharmacol Sci. 2020;24:4940–4953.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Zhou XQ, Chang YZ, Zhu LR, et al. LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression. Bioengineered. 2021;12:10849–10861.
   PubMed Web of Science ®Google Scholar
• Tang Q, Chen Z, Zhao L, et al. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1. Aging (Albany NY). 2019;11:9982–9999.
   PubMedGoogle Scholar
• Kumar P, Nagarajan A, and Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018;20183 469–471.
   Google Scholar
• Kim B. Western Blot Techniques. Methods Mol Biol. 2017;1606:133–139.
   PubMedGoogle Scholar
• Telford WG. Multiparametric analysis of apoptosis by flow cytometry. Methods Mol Biol. 2018;1678:167–202.
   PubMedGoogle Scholar
• Zhao W, Geng D, Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7:842–855.
   PubMed Web of Science ®Google Scholar
• Dong H, Diao H, Zhao Y, et al. Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling. Cell Prolif. 2019;52:e12633.
   PubMed Web of Science ®Google Scholar
• Pittayapruek P, Meephansan J, Prapapan O, et al. Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci. 2016;17:868.
   PubMed Web of Science ®Google Scholar
• McMahon CM, Luger SM. Relapsed T cell ALL: current approaches and new directions. Curr Hematol Malig Rep. 2019;14:83–93.
   PubMed Web of Science ®Google Scholar
• Huang X, Huang L, Xie Q, et al. LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL. Biomark Res. 2021;9:45.
   PubMed Web of Science ®Google Scholar
• Wallaert A, Durinck K, Van Loocke W, et al. Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia. Leukemia. 2016;30:1927–1930.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Mohammad-Rahimi H, Taheri M. The role of long non-coding RNAs in the pathogenesis of thyroid cancer. Exp Mol Pathol. 2020;112:104332.
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–348.
   PubMed Web of Science ®Google Scholar
• Duff D, Long A. Roles for RACK1 in cancer cell migration and invasion. Cell Signal. 2017;35:250–255.
   PubMed Web of Science ®Google Scholar
• Cardano M, Tribioli C, Prosperi E. Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation. Curr Cancer Drug Targets. 2020;20:240–252.
   PubMed Web of Science ®Google Scholar
• Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99–104.
   PubMed Web of Science ®Google Scholar
• Mondal S, Adhikari N, Banerjee S, et al. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur J Med Chem. 2020;194:112260.
   PubMed Web of Science ®Google Scholar